These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 24411198)

  • 1. Synthesis and biological evaluation of novel oxadiazole derivatives: a new class of thymidine phosphorylase inhibitors as potential anti-tumor agents.
    Shahzad SA; Yar M; Bajda M; Jadoon B; Khan ZA; Naqvi SA; Shaikh AJ; Hayat K; Mahmmod A; Mahmood N; Filipek S
    Bioorg Med Chem; 2014 Feb; 22(3):1008-15. PubMed ID: 24411198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, thymidine phosphorylase inhibitory and computational study of novel 1,3,4-oxadiazole-2-thione derivatives as potential anticancer agents.
    Bajaj S; Roy PP; Singh J
    Comput Biol Chem; 2018 Oct; 76():151-160. PubMed ID: 30015176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, thymidine phosphorylase inhibition and molecular modeling studies of 1,3,4-oxadiazole-2-thione derivatives.
    Shahzad SA; Yar M; Bajda M; Shahzadi L; Khan ZA; Naqvi SA; Mutahir S; Mahmood N; Khan KM
    Bioorg Chem; 2015 Jun; 60():37-41. PubMed ID: 25920005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, modelling studies and biological evaluation of 1,3,4-oxadiazole derivatives as potent anticancer agents targeting thymidine phosphorylase enzyme.
    Bajaj S; Kumar MS; Tinwala H; Yc M
    Bioorg Chem; 2021 Jun; 111():104873. PubMed ID: 33845381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, molecular docking study and in vitro thymidine phosphorylase inhibitory potential of oxadiazole derivatives.
    Ullah H; Rahim F; Taha M; Uddin I; Wadood A; Shah SAA; Farooq RK; Nawaz M; Wahab Z; Khan KM
    Bioorg Chem; 2018 Aug; 78():58-67. PubMed ID: 29533215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, SAR elucidations and molecular docking study of newly designed isatin based oxadiazole analogs as potent inhibitors of thymidine phosphorylase.
    Javid MT; Rahim F; Taha M; Nawaz M; Wadood A; Ali M; Mosaddik A; Shah SAA; Farooq RK
    Bioorg Chem; 2018 Sep; 79():323-333. PubMed ID: 29803079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.
    Sun J; Zhu H; Yang ZM; Zhu HL
    Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents.
    Zhang XM; Qiu M; Sun J; Zhang YB; Yang YS; Wang XL; Tang JF; Zhu HL
    Bioorg Med Chem; 2011 Nov; 19(21):6518-24. PubMed ID: 21962523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives: promising anticancer agents.
    Aboraia AS; Abdel-Rahman HM; Mahfouz NM; El-Gendy MA
    Bioorg Med Chem; 2006 Feb; 14(4):1236-46. PubMed ID: 16242340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, evaluation of thymidine phosphorylase and angiogenic inhibitory potential of ciprofloxacin analogues: Repositioning of ciprofloxacin from antibiotic to future anticancer drugs.
    Shahzad SA; Sarfraz A; Yar M; Khan ZA; Naqvi SAR; Naz S; Khan NA; Farooq U; Batool R; Ali M
    Bioorg Chem; 2020 Jul; 100():103876. PubMed ID: 32388426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of novel 1-(aryl-aldehyde-oxime)uracil derivatives as a new class of thymidine phosphorylase inhibitors.
    Zhao S; Li K; Jin Y; Lin J
    Eur J Med Chem; 2018 Jan; 144():41-51. PubMed ID: 29247859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological evaluation, and molecular docking studies of novel 1,3,4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity.
    Zhang S; Luo Y; He LQ; Liu ZJ; Jiang AQ; Yang YH; Zhu HL
    Bioorg Med Chem; 2013 Jul; 21(13):3723-9. PubMed ID: 23673215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design of bis-indolylmethane-oxadiazole hybrids as inhibitors of thymidine phosphorylase.
    Taha M; Rashid U; Imran S; Ali M
    Bioorg Med Chem; 2018 Jul; 26(12):3654-3663. PubMed ID: 29853339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological evaluation, and molecular docking studies of 2-chloropyridine derivatives possessing 1,3,4-oxadiazole moiety as potential antitumor agents.
    Zheng QZ; Zhang XM; Xu Y; Cheng K; Jiao QC; Zhu HL
    Bioorg Med Chem; 2010 Nov; 18(22):7836-41. PubMed ID: 20947362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of 1,2,4-triazoles as new thymidine phosphorylase inhibitors: Future anti-tumor drugs.
    Shahzad SA; Yar M; Khan ZA; Shahzadi L; Naqvi SAR; Mahmood A; Ullah S; Shaikh AJ; Sherazi TA; Bale AT; Kukułowicz J; Bajda M
    Bioorg Chem; 2019 Apr; 85():209-220. PubMed ID: 30634096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, anti-thymidine phosphorylase activity and molecular docking of 5-thioxo-[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-ones.
    Bera H; Lee MH; Sun L; Dolzhenko AV; Chui WK
    Bioorg Chem; 2013 Oct; 50():34-40. PubMed ID: 23968897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico binding analysis and SAR elucidations of newly designed benzopyrazine analogs as potent inhibitors of thymidine phosphorylase.
    Taha M; Ismail NH; Imran S; Rahim F; Wadood A; Al Muqarrabun LM; Khan KM; Ghufran M; Ali M
    Bioorg Chem; 2016 Oct; 68():80-9. PubMed ID: 27474803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Arylquinazolin-4(3H)-ones: A novel class of thymidine phosphorylase inhibitors.
    Javaid S; Saad SM; Perveen S; Khan KM; Choudhary MI
    Bioorg Chem; 2015 Dec; 63():142-51. PubMed ID: 26547232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and molecular docking study of piperazine derivatives as potent inhibitor of thymidine phosphorylase.
    Uddin I; Taha M; Rahim F; Wadood A
    Bioorg Chem; 2018 Aug; 78():324-331. PubMed ID: 29626638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, in-vitro thymidine phosphorylase inhibition, in-vivo antiangiogenic and in-silico studies of C-6 substituted dihydropyrimidines.
    Iftikhar F; Yaqoob F; Tabassum N; Jan MS; Sadiq A; Tahir S; Batool T; Niaz B; Ansari FL; Choudhary MI; Rashid U
    Bioorg Chem; 2018 Oct; 80():99-111. PubMed ID: 29894893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.